Skip to content
Lower risk Drug recall · FDA · Published May 1, 2026

Amerisource Health Primidone Tablets Recall: Cross Contamination Risk

Amerisource Health Services recalls Primidone 50mg tablets due to cross contamination with Acemetacin. Affected lots may pose health risks if taken.

🇺🇸 FDA recall #D-0537-2026DrugAmerisource Health Services ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

What happened, in plain English

Amerisource Health Services is recalling Primidone 50mg tablets that may contain trace amounts of Acemetacin from cross contamination. This could cause health issues if taken by people who need the medication. Read more at govinfonow.com/recall/31318-amerisource-health-primidone-tablets-recall-cross-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31318-amerisource-health-primidone-tablets-recall-cross-contamination-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0537-2026

Cite this page

“Amerisource Health Primidone Tablets Recall: Cross Contamination Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31318-amerisource-health-primidone-tablets-recall-cross-contamination-risk. Based on FDA recall #D-0537-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0537-2026%22&limit=1).

Why it’s dangerous

The tablets may have been contaminated with trace amounts of Acemetacin during manufacturing. This cross contamination could lead to unintended medication effects if taken by patients.

Who’s affected

People with prescriptions for Primidone 50mg tablets who received these specific lots are affected. Those with medical conditions requiring this medication are most at risk.

How to tell if you have this one

Check your carton for NDC 68084-202-01 or individual dose NDC 68084-202-11. Look for lot numbers 1028739 (expiring 12/31/2027) or 1025622 (expiring 06/30/2027).

  • Brand
    Amerisource Health Services
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Ongoing
  • Distribution
    USA Nationwide
  • NDC
    68084-203-11, 68084-203-01, 68084-202-11, 68084-202-01
Recall numberProduct, codes & lotsQuantity
D-0536-2026Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-203-01; Individual Dose NDC: 68084-203-11; Lot#: 1027583, Exp 09/30/202763,500 tablets
D-0537-2026Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-202-01; Individual Dose NDC: 68084-202-11; Lot 1028739, exp 12/31/2027; Lot 1025622, exp 06/30/2027225,000 tablets
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify your carton has NDC 68084-202-01 or individual dose NDC 68084-202-11 with the specified lot numbers.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: May 1, 202612. FDA classified it Class III: May 18, 202623. Published in FDA’s Enforcement Report: May 27, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Amerisource Health Services recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0537-2026 (May 1, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0537-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA